Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks

2015161 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Journal of Hepatology

Volume 64, Issue 2, pp. 301-307

Field-Weighted Citation Impact: 18.12